Back
Bright Minds Biosciences Stock Price Chart
Sponsored
DRUG.CX
Sponsored
A 10,000% Dividend?!?
Watch the short presentation by clicking here.
Sell
33
DRUG.CX
Bright Minds Biosciences
Last Price:
53.33
Seasonality Move:
-19.1%
7 Day Trial
ALL ACCESS PASS
$
7
The #1 Energy Passive Income Investment for 2023The #1 Energy Passive Income Investment for 2024
CLICK HERE TO FIND OUT WHAT IT IS.- The current trend is moderately bearish and DRUG.CX is experiencing selling pressure, which indicates risk of future bearish movement.
Bright Minds Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.38 | Sell |
20-day SMA: | 55.63 | Sell |
50-day SMA: | 49.57 | Buy |
200-day SMA: | 13.56 | Buy |
8-day EMA: | 56.46 | Sell |
20-day EMA: | 56.55 | Sell |
50-day EMA: | 47.73 | Buy |
200-day EMA: | 21.33 | Buy |
Bright Minds Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.31 | Buy |
Relative Strength Index (14 RSI): | 48.03 | Sell |
Chaikin Money Flow: | -902 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.44 - 64.72) | Sell |
Bollinger Bands (100): | (-4.27 - 55.29) | Buy |
Bright Minds Biosciences Technical Analysis
Nov 27 | Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Bright Minds Biosciences Stock
Is Bright Minds Biosciences Stock a Buy?
- Bright Minds Biosciences share price is 53.33 while DRUG.CX 8-day simple moving average is 59.38, which is a Sell signal.
- The stock price of DRUG.CX is 53.33 while Bright Minds Biosciences 20-day SMA is 55.63, which makes it a Sell.
- Bright Minds Biosciences 50-day simple moving average is 49.57 while DRUG.CX share price is 53.33, making it a Buy technically.
- DRUG.CX stock price is 53.33 and Bright Minds Biosciences 200-day simple moving average is 13.56, creating a Buy signal.
DRUG.CX Technical Analysis vs Fundamental Analysis
Sell
33
Bright Minds Biosciences (DRUG.CX)
is a Sell
Is Bright Minds Biosciences a Buy or a Sell?
-
Bright Minds Biosciences stock is rated a Sell
The current Bright Minds Biosciences [DRUG.CX] share price is $53.33. The Score for DRUG.CX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Bright Minds Biosciences Stock Info
Market Cap:
238.05M
Price in USD:
53.33
Share Volume:
902
Bright Minds Biosciences 52-Week Range
52-Week High:
108.00
52-Week Low:
1.29
Sell
33
Bright Minds Biosciences (DRUG.CX)
is a Sell
Bright Minds Biosciences Share Price Forecast
-
What is the Bright Minds Biosciences stock price today?
The Bright Minds Biosciences stock price is 53.33 USD today. -
Will DRUG.CX stock go up or go down?
Bright Minds Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Bright Minds Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bright Minds Biosciences is overvalued.
Is Bright Minds Biosciences Stock a Buy?
- Bright Minds Biosciences share price is 53.33 while DRUG.CX 8-day exponential moving average is 56.46, which is a Sell signal.
- The stock price of DRUG.CX is 53.33 while Bright Minds Biosciences 20-day EMA is 56.55, which makes it a Sell.
- Bright Minds Biosciences 50-day exponential moving average is 47.73 while DRUG.CX share price is 53.33, making it a Buy technically.
- DRUG.CX stock price is 53.33 and Bright Minds Biosciences 200-day simple moving average is 21.33, creating a Buy signal.
Fundamental Analysis of Bright Minds Biosciences
Is Bright Minds Biosciences a good investment?
- Analysts estimate an earnings decrease this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $4.02 per share.
Technical Analysis of Bright Minds Biosciences
Should I short Bright Minds Biosciences stock?
- DRUG.CX Moving Average Covergence Divergence (MACD) indicator is 1.31, suggesting Bright Minds Biosciences is a Buy
- Bright Minds Biosciences Relative Strength Index (RSI) is 48.03, which suggest Bright Minds Biosciences is oversold
- The Bollinger Bands (25) for Bright Minds Biosciences is (50.44 - 64.72), which suggest Bright Minds Biosciences is a Buy
- The Bollinger Bands (100) for Bright Minds Biosciences is (-4.27 - 55.29), which suggest Bright Minds Biosciences is a Buy
* Bright Minds Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.